NeuroPace (NPCE) Stock Chart & Stock Price History $8.93 -0.06 (-0.67%) Closing price 08/4/2025 04:00 PM EasternExtended Trading$10.00 +1.07 (+11.98%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NeuroPace Stock Price Performance The NeuroPace (NPCE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 28.30%, with a year-to-date return of -20.20%. In the past month, the stock has decreased 12.67%, reflecting recent market activity. As of the latest close, NeuroPace traded at $8.93 with a market cap of $294.86 million and volume of 129,994 shares. Receive NPCE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroPace and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.94%1 Month Performance-12.67%3 Month Performance-22.55%Year-To-Date Performance-20.20%1 Year Performance+28.30% NPCE Stock Chart for Tuesday, August, 5, 2025 NPCE Chart by TradingView NeuroPace Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/04/2025$8.99$8.93-0.67%$9.13$8.87129,994 shs$294.86 million08/01/2025$8.51$8.99+5.64%$9.06$8.25247,015 shs$294.86 million07/31/2025$8.76$8.51-2.85%$8.78$8.49110,393 shs$279.13 million07/30/2025$8.78$8.76-0.23%$9.09$8.65157,378 shs$287.33 million07/29/2025$8.74$8.78+0.46%$8.88$8.59179,229 shs$287.98 million07/28/2025$8.98$8.74-2.67%$9.00$8.70109,245 shs$286.67 million07/25/2025$9.07$8.98-0.99%$9.13$8.79374,471 shs$294.54 million07/24/2025$9.50$9.07-4.53%$9.45$9.06177,803 shs$297.50 million07/23/2025$9.35$9.50+1.60%$9.61$9.26200,988 shs$311.59 million07/22/2025$9.36$9.35-0.11%$9.46$9.15229,942 shs$306.68 million Get the Latest News and Ratings for NPCE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroPace and its competitors with MarketBeat's FREE daily newsletter. 07/21/2025$9.06$9.36+3.31%$9.40$9.00262,856 shs$307.01 million07/18/2025$9.08$9.06-0.22%$9.36$9.01132,242 shs$297.17 million07/17/2025$9.11$9.08-0.33%$9.41$9.04191,406 shs$297.82 million07/16/2025$9.35$9.11-2.57%$9.43$8.97260,312 shs$298.81 million07/15/2025$9.55$9.35-2.09%$9.58$9.26191,786 shs$306.67 million07/14/2025$9.52$9.55+0.32%$9.64$9.24198,855 shs$313.23 million07/11/2025$10.17$9.52-6.39%$10.27$9.50232,549 shs$312.26 million07/10/2025$10.08$10.17+0.89%$10.39$9.95301,688 shs$333.58 million07/09/2025$10.36$10.08-2.70%$10.58$9.91274,438 shs$330.62 million07/08/2025$10.22$10.36+1.37%$10.38$10.10138,603 shs$339.81 million07/07/2025$10.23$10.22-0.05%$10.60$10.05223,411 shs$335.21 million07/04/2025$10.23$10.23$10.64$10.2484,321 shs$335.37 million Related Companies BioLife Solutions Stock Price Chart Tandem Diabetes Care Stock Price Chart Pulse Biosciences Stock Price Chart MiMedx Group Stock Price Chart InMode Stock Price Chart Kestra Medical Technologies Stock Price Chart SiBone Stock Price Chart iRadimed Stock Price Chart Embecta Stock Price Chart Beta Bionics Stock Price Chart Receive NPCE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroPace and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NPCE) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroPace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroPace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
